Clinical update on AMG 420, an anti-BCMA BiTE®
PharmaTalkRadio1 Nov 2019

Clinical update on AMG 420, an anti-BCMA BiTE®

In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy) Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
sinnsyn
rss-nysgjerrige-norge
forskningno
dekodet-2
liberal-halvtime
rekommandert
rss-paradigmepodden
fjellsportpodden
rss-rekommandert
tidlose-historier
villmarksliv
jss
grunnstoffene
hva-er-greia-med
rss-bondevennen
tomprat-med-gunnar-tjomlid
nordnorsk-historie